Search Results
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Jordan S F Chan in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Amanda A Greenwell in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Christina T Saed in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Magnus J Stenlund in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Indiresh A Mangra-Bala in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Seyed Amirhossein Tabatabaei Dakhili in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Kunyan Yang in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Sally R Ferrari in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Farah Eaton in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Keshav Gopal in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by John R Ussher in
Google Scholar
PubMed
oxidation secondary to the stimulation of pyruvate dehydrogenase (PDH) activity ( Almutairi et al. 2021 ), the rate-limiting enzyme of glucose oxidation ( Patel et al. 2014 ). These actions on myocardial glucose oxidation appear to be indirectly mediated
Search for other papers by MC Sugden in
Google Scholar
PubMed
Search for other papers by HS Lall in
Google Scholar
PubMed
Search for other papers by RA Harris in
Google Scholar
PubMed
Search for other papers by MJ Holness in
Google Scholar
PubMed
The pyruvate dehydrogenase kinases (PDK1-4) regulate glucose oxidation through inhibitory phosphorylation of the pyruvate dehydrogenase complex (PDC). Immunoblot analysis with antibodies raised against recombinant PDK isoforms demonstrated changes in PDK isoform expression in response to experimental hyperthyroidism (100 microg/100 g body weight; 3 days) that was selective for fast-twitch vs slow-twitch skeletal muscle in that PDK2 expression was increased in the fast-twitch skeletal muscle (the anterior tibialis) (by 1. 6-fold; P<0.05) but not in the slow-twitch muscle (the soleus). PDK4 protein expression was increased by experimental hyperthyroidism in both muscle types, there being a greater response in the anterior tibialis (4.2-fold increase; P<0.05) than in the soleus (3.2-fold increase; P<0.05). The hyperthyroidism-associated up-regulation of PDK4 expression was observed in conjunction with suppression of skeletal-muscle PDC activity, but not suppression of glucose uptake/phosphorylation, as measured in vivo in conscious unrestrained rats (using the 2-[(3)H]deoxyglucose technique). We propose that increased PDK isoform expression contributes to the pathology of hyperthyroidism and to PDC inactivation by facilitating the operation of the glucose --> lactate --> glucose (Cori) and glucose --> alanine --> glucose cycles. We also propose that enhanced relative expression of the pyruvate-insensitive PDK isoform (PDK4) in skeletal muscle in hyperthyroidism uncouples glycolytic flux from pyruvate oxidation, sparing pyruvate for non-oxidative entry into the tricarboxylic acid (TCA) cycle, and thereby supporting entry of acetyl-CoA (derived from fatty acid oxidation) into the TCA cycle.
Search for other papers by Natalia Pavón in
Google Scholar
PubMed
Search for other papers by Alfredo Cabrera-Orefice in
Google Scholar
PubMed
Search for other papers by Juan Carlos Gallardo-Pérez in
Google Scholar
PubMed
Search for other papers by Cristina Uribe-Alvarez in
Google Scholar
PubMed
Search for other papers by Nadia A Rivero-Segura in
Google Scholar
PubMed
Search for other papers by Edgar Ricardo Vazquez-Martínez in
Google Scholar
PubMed
Search for other papers by Marco Cerbón in
Google Scholar
PubMed
Search for other papers by Eduardo Martínez-Abundis in
Google Scholar
PubMed
Search for other papers by Juan Carlos Torres-Narvaez in
Google Scholar
PubMed
Search for other papers by Raúl Martínez-Memije in
Google Scholar
PubMed
Search for other papers by Francisco-Javier Roldán-Gómez in
Google Scholar
PubMed
Search for other papers by Salvador Uribe-Carvajal in
Google Scholar
PubMed
capacity and antioxidant defenses ( Nadal-Casellas et al . 2011 ), as well as complex IV (COX) and pyruvate dehydrogenase (PDH) activities in whole-brain mitochondria ( Irwin et al . 2011 ). However, these changes have not been fully explored in heart
Department of Pharmacology, School of Biomedical Sciences, UNSW Sydney, New South Wales, Australia
Department of Cellular and Molecular Medicine, Center for Healthy Aging, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Brenna Osborne in
Google Scholar
PubMed
Search for other papers by Lauren E Wright in
Google Scholar
PubMed
Charles Perkins Centre, University of Sydney, New South Wales, Australia
Search for other papers by Amanda E Brandon in
Google Scholar
PubMed
Search for other papers by Ella Stuart in
Google Scholar
PubMed
Search for other papers by Lewin Small in
Google Scholar
PubMed
Search for other papers by Joris Hoeks in
Google Scholar
PubMed
Search for other papers by Patrick Schrauwen in
Google Scholar
PubMed
Search for other papers by David A Sinclair in
Google Scholar
PubMed
Department of Anatomy & Physiology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Magdalene K Montgomery in
Google Scholar
PubMed
Charles Perkins Centre, University of Sydney, New South Wales, Australia
Search for other papers by Gregory J Cooney in
Google Scholar
PubMed
Department of Pharmacology, School of Biomedical Sciences, UNSW Sydney, New South Wales, Australia
Cellular Bioenergetics Laboratory, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
Search for other papers by Nigel Turner in
Google Scholar
PubMed
presence of 0 mM, 0.2 mM, 0.5 mM, 1 mM or 2 mM pyruvate. Oxidative enzyme activity The maximal activity of citrate synthase (CS), succinate dehydrogenase (SDH), hexokinase (HK), isocitrate dehydrogenase (IDH) and active pyruvate dehydrogenase (PDH
Search for other papers by Ricardo J Samms in
Google Scholar
PubMed
Search for other papers by Michelle Murphy in
Google Scholar
PubMed
Search for other papers by Maxine J Fowler in
Google Scholar
PubMed
Search for other papers by Scott Cooper in
Google Scholar
PubMed
Search for other papers by Paul Emmerson in
Google Scholar
PubMed
Search for other papers by Tamer Coskun in
Google Scholar
PubMed
Search for other papers by Andrew C Adams in
Google Scholar
PubMed
Search for other papers by Alexei Kharitonenkov in
Google Scholar
PubMed
Search for other papers by Francis J P Ebling in
Google Scholar
PubMed
Search for other papers by Kostas Tsintzas in
Google Scholar
PubMed
dehydrogenase complex activity (PDC, mmol/min per kg dm), (B) acetylcarnitine (mmol/kg dm) and (C) pyruvate dehydrogenase 4 (PDK4) at the end of the 14-day treatment period. Values are group means± s.e.m. * P <0.05 vs vehicle. Figure 4 The effect of vehicle ( n
Search for other papers by Cristina Mora in
Google Scholar
PubMed
Search for other papers by Cristina Pintado in
Google Scholar
PubMed
Search for other papers by Blanca Rubio in
Google Scholar
PubMed
Search for other papers by Lorena Mazuecos in
Google Scholar
PubMed
Search for other papers by Virginia López in
Google Scholar
PubMed
Search for other papers by Alejandro Fernández in
Google Scholar
PubMed
Search for other papers by Aurora Salamanca in
Google Scholar
PubMed
Search for other papers by Brenda Bárcena in
Google Scholar
PubMed
Search for other papers by Teresa Fernández-Agulló in
Google Scholar
PubMed
Search for other papers by Carmen Arribas in
Google Scholar
PubMed
Search for other papers by Nilda Gallardo in
Google Scholar
PubMed
Search for other papers by Antonio Andrés in
Google Scholar
PubMed
of PDK4 expression might suggest a decrease in glucose oxidation through pyruvate dehydrogenase. Nevertheless, we studied an alternate route for glucose oxidation, the anaplerotic cytoplasmic malic enzyme, as a compensatory pathway that may contribute
Search for other papers by Firoozeh Salehzadeh in
Google Scholar
PubMed
Search for other papers by Anna Rune in
Google Scholar
PubMed
Search for other papers by Megan Osler in
Google Scholar
PubMed
Search for other papers by Lubna Al-Khalili in
Google Scholar
PubMed
transporter 4; GLUT4 ( SLC2A4 ) and pyruvate dehydrogenase kinase isozyme 4 ( PDK4 ), carnitine palmitoyltransferase 1 ( CPT1 ), IRS2 , stearoyl-CoA desaturase ( SCD ), peroxisome proliferator-activated receptor delta ( PPARD ) and gamma ( PPARG ), fatty acid
Search for other papers by Olivier Dumortier in
Google Scholar
PubMed
Université Côte d’Azur, CNRS, LP2M, Nice, France
Search for other papers by Gaia Fabris in
Google Scholar
PubMed
Search for other papers by Didier F Pisani in
Google Scholar
PubMed
Search for other papers by Virginie Casamento in
Google Scholar
PubMed
Search for other papers by Nadine Gautier in
Google Scholar
PubMed
Search for other papers by Charlotte Hinault in
Google Scholar
PubMed
Search for other papers by Patricia Lebrun in
Google Scholar
PubMed
Search for other papers by Christophe Duranton in
Google Scholar
PubMed
Search for other papers by Michel Tauc in
Google Scholar
PubMed
Search for other papers by Stéphane Dalle in
Google Scholar
PubMed
Search for other papers by Julie Kerr-Conte in
Google Scholar
PubMed
Search for other papers by François Pattou in
Google Scholar
PubMed
Search for other papers by Marc Prentki in
Google Scholar
PubMed
Université Côte d’Azur, CHU, Inserm, CNRS, IRCAN, Nice, France
Université Côte d’Azur, CHU, CNRS, LP2M, Nice, France
Search for other papers by Emmanuel Van Obberghen in
Google Scholar
PubMed
pyruvate ( Fig. 4E ). In differentiated beta cells, pyruvate is slightly reduced to lactate and hence most of the glucose-derived pyruvate is metabolized in the mitochondria via pyruvate dehydrogenase and anaplerotic reactions ( Ainscow et al . 2000
Search for other papers by Richard R Almon in
Google Scholar
PubMed
Search for other papers by Debra C DuBois in
Google Scholar
PubMed
Search for other papers by Jin Y Jin in
Google Scholar
PubMed
Search for other papers by William J Jusko in
Google Scholar
PubMed
section of the tree containing these three probe sets (Fig. 3 , middle) shows that two of the probe sets are for uncoupling protein 3 (UCP3) and one is for pyruvate dehydrogenase kinase isoenzyme 4 (PDK4). Figure 3 (right) shows an enlargement of the
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Jordan S F Chan in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by Tanin Shafaati in
Google Scholar
PubMed
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada
Search for other papers by John R Ussher in
Google Scholar
PubMed
glucose uptake is a key contributor to the T2D-mediated decline in myocardial glucose oxidation, there are also several important molecular factors at play. The most important is the marked impairment in the activity of pyruvate dehydrogenase (PDH), the